The VISIBLE Study: Understanding Comorbidities in Psoriasis Across All Skin Tones

An expert discusses how the VISIBLE study examined comorbidity burden in moderate to severe psoriasis across all skin tones, addressing disparities in research. It aimed to highlight unmet needs and improve understanding of disease impact in diverse populations.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.Real-World Insights on Tildrakizumab

EP: 2.Tildrakizumab in Practice: Adherence and Clinical Takeaways

Now Viewing

EP: 3.The VISIBLE Study: Understanding Comorbidities in Psoriasis Across All Skin Tones

EP: 4.Comparing Biologic Treatment Patterns: Tildrakizumab vs Ustekinumab

Video content above is prompted by the following:

• What is the key background of the VISIBLE study, which examined the burden of comorbidities in participants with moderate to severe psoriasis across all skin tones?
  • What do you believe was the impetus for this study?

Related Videos

Comparing Biologic Treatment Patterns: Tildrakizumab vs Ustekinumab

Tildrakizumab in Practice: Adherence and Clinical Takeaways

Real-World Insights on Tildrakizumab